Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Aditxt ( (ADTX) ) is now available.
Aditxt, Inc. has been actively working on a merger with Evofem Biosciences, Inc., with the latter becoming a wholly owned subsidiary. The merger agreement has undergone several amendments, with the latest being Amendment No. 6 on August 26, 2025. These amendments have included changes to investment amounts, dates, and shareholder approval definitions, reflecting ongoing negotiations and adjustments in the merger process.
More about Aditxt
Average Trading Volume: 842,954
Technical Sentiment Signal: Strong Sell
Current Market Cap: $5.28M
See more insights into ADTX stock on TipRanks’ Stock Analysis page.